BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 28554777)

  • 1. [Prostate cancer histoseminar: Update of the 2016 WHO classification - case n
    Compérat E
    Ann Pathol; 2017 Jun; 37(3):228-231. PubMed ID: 28554777
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prostate cancer histoseminar: Update of the 2016 WHO classification - case n
    Leroy X
    Ann Pathol; 2017 Jun; 37(3):245-248. PubMed ID: 28554778
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prostate cancer histoseminar: Update of the 2016 WHO classification - case No. 8: Acinar prostatic adenocarcinoma, Gleason score 6 (3+3)].
    Ferlicot S
    Ann Pathol; 2017 Jun; 37(3):259-263. PubMed ID: 28522121
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prostate cancer histoseminar: Update of the 2016 WHO classification - case n
    Compérat E
    Ann Pathol; 2017 Jun; 37(3):232-234. PubMed ID: 28554779
    [No Abstract]   [Full Text] [Related]  

  • 5. Collision tumour involving a rectal gastrointestinal stromal tumour with invasion of the prostate and a prostatic adenocarcinoma.
    Macías-García L; De la Hoz-Herazo H; Robles-Frías A; Pareja-Megía MJ; López-Garrido J; López JI
    Diagn Pathol; 2012 Oct; 7():150. PubMed ID: 23111239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic challenges of clonal heterogeneity in prostate cancer.
    Haffner MC; De Marzo AM; Yegnasubramanian S; Epstein JI; Carter HB
    J Clin Oncol; 2015 Mar; 33(7):e38-40. PubMed ID: 24638011
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prostate cancer histoseminar: Update of the 2016 WHO classification - case n
    Leroy X
    Ann Pathol; 2017 Jun; 37(3):241-244. PubMed ID: 28522125
    [No Abstract]   [Full Text] [Related]  

  • 8. OA-519 (fatty acid synthase) as an independent predictor of pathologic state in adenocarcinoma of the prostate.
    Epstein JI; Carmichael M; Partin AW
    Urology; 1995 Jan; 45(1):81-6. PubMed ID: 7817483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is undetectable prostate-specific antigen always reliable to rule out prostate cancer recurrence after radical prostatectomy?
    Schriefer P; Steurer S; Huland H; Graefen M
    J Clin Oncol; 2012 Nov; 30(32):e341-4. PubMed ID: 23032622
    [No Abstract]   [Full Text] [Related]  

  • 10. Adenoid cystic carcinoma of the urethra/Cowper's gland with concurrent high-grade prostatic adenocarcinoma: a detailed clinicopathologic case report and review of the literature.
    Zhang M; Pettaway C; Vikram R; Tamboli P
    Hum Pathol; 2016 Dec; 58():138-144. PubMed ID: 27554206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Histomorphologic studies of prostate biopsies, prostatectomy preparations and lymph node metastases in prostatic cancer].
    Schubert J; Battke H; Hoffmann L; Raatzsch H
    Z Urol Nephrol; 1984 Sep; 77(9):521-8. PubMed ID: 6506894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical expression of Ets-related gene-transcriptional factor in adenocarcinoma prostate and its correlation with Gleason score.
    Mannan R; Bhasin TS; Manjari M; Singh G; Bhatia PK; Sharma S
    Indian J Pathol Microbiol; 2016; 59(4):489-495. PubMed ID: 27721279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synchronous mantle cell lymphoma and prostate adenocarcinoma-is it just a coincidence?
    Petković I; Stojnev S; Krstić M; Pejčić I; Vrbić S
    Vojnosanit Pregl; 2016 Nov; 73(11):1072-5. PubMed ID: 29341562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidental Prostate Adenocarcinoma in Cystoprostatectomy Specimens: Partial Versus Complete Prostate Sampling.
    Filter ER; Gabril MY; Gomez JA; Wang PZT; Chin JL; Izawa J; Moussa M
    Int J Surg Pathol; 2017 Aug; 25(5):414-420. PubMed ID: 28381150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unusual metastatic features in a patient with concomitant malignant orbital melanoma and prostate carcinoma.
    Ars C; Duck L; Baurain JF; Moulin P; Duprez T; Machiels JP
    J Neurooncol; 2004 Feb; 66(3):361-3. PubMed ID: 15015669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenocarcinoma of the prostate with Gleason score 9-10 on core biopsy: correlation with findings at radical prostatectomy and prognosis.
    Ellis CL; Partin AW; Han M; Epstein JI
    J Urol; 2013 Dec; 190(6):2068-73. PubMed ID: 23727307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of plasma intermedin levels with progression and metastasis in men after radical prostatectomy for localized prostatic cancer.
    Wang XL; Wang YY; He HD; Xie X; Yu ZJ; Pan YM
    Cancer Biomark; 2015; 15(6):799-805. PubMed ID: 26406405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of tumor-associated macrophages in the Hexim1 and TGFβ/SMAD pathway, and their influence on progression of prostatic adenocarcinoma.
    Ok Atılgan A; Özdemir BH; Akçay EY; Ataol Demirkan Ö; Tekindal MA; Özkardeş H
    Pathol Res Pract; 2016 Feb; 212(2):83-92. PubMed ID: 26608417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collision metastasis of bladder and prostate carcinoma to a single pelvic lymph node.
    Ergen A; Balbay MD; Irwin M; Torno R
    Int Urol Nephrol; 1995; 27(6):743-5. PubMed ID: 8725040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prostate cancer histoseminar: Update of the 2016 WHO classification - case n
    Ferlicot S
    Ann Pathol; 2017 Jun; 37(3):235-240. PubMed ID: 28522123
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.